Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Top Cited Papers
- 24 December 2010
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 330 (6012) , 1774
- https://doi.org/10.1126/science.1197623
Abstract
Alzheimer’s disease is associated with reduced β-amyloid clearance from the brainKeywords
This publication has 7 references indexed in Scilit:
- A γ‐secretase inhibitor decreases amyloid‐β production in the central nervous systemAnnals of Neurology, 2009
- Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivoNature Medicine, 2006
- Alzheimer's DiseaseNew England Journal of Medicine, 2004
- ApoE and Clusterin Cooperatively Suppress Aβ Levels and DepositionNeuron, 2004
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's diseaseNature Medicine, 1996
- Cerebral amyloid angiopathy in the brains of patients with Alzheimer's diseaseNeurology, 1996